coronary artery disease - revascularization with drug eluting stent - bifurcation lesion clinical trials results meta-analysis

<h1> <a href="TM29-79-revascularization with drug eluting stent-coronary artery disease" > <strong>coronary artery disease</strong> - revascularization with drug eluting stent </a> - bifurcation lesion trial results systematic overview and meta-analysis </h1> <h2>Main characteristics of the included studies</h2> <table> <tr> <th>Trial</th> <th>Treatments</th> <th>Patients</th> <th>Methods</th> </tr> <tr> <td> <a href="../TRC_t8657.htm"> Pan, 2007 </a> <br> </td> <td> SES<br>  <i>versus</i> <br> PES </td> <td> patients with bifurcation lesions </td> <td> follow-up 24 months (mean)<br> n=103/102<br> Parallel groups<br> open <br> Spain </td> </tr> <tr> <td> <a href="../TRC_t9977.htm"> Nordic-Baltic Bifurcation Study III, 2009 </a> <br> </td> <td> Kissing balloon dilatation post-stenting of the main artery (one-stent technique)<br>  <i>versus</i> <br> no kissing balloon dilatation </td> <td> patients with bifurcation lesions </td> <td> follow-up 6 mo<br> n=238/239<br> Parallel groups<br> <br> </td> </tr> <tr> <td> <a href="../TRC_t6647.htm"> Nordic Bifurcation Study, 0 </a> <br> NCT00376571 </td> <td> Strategy of Routine Stenting Both Main Vessel and Side Branch<br>  <i>versus</i> <br> Strategy of Routine Main Vessel Stenting and Optional Treatment of Side Branch </td> <td> bifurcation lesions </td> <td> follow-up <br> n=-9/-9<br> <br> <br> </td> </tr> <tr> <td> <a href="../TRC_t6659.htm"> Nordic Bifurcation Stent Technique Study, 0 </a> <br> NCT00292305 </td> <td> crush stenting<br>  <i>versus</i> <br> culotte stenting </td> <td> bifurcation lesions </td> <td> follow-up <br> n=-9/-9<br> <br> <br> </td> </tr> </table> <h2>References</h2> <p> <b>Pan, 2007 : </b> Pan M, Surez de Lezo J, Medina A, Romero M, Delgado A, Segura J, Ojeda S, Mazuelos F, Hernandez E, Melian F, Pavlovic D, Esteban F, Herrador JDrug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. <i>Am Heart J 2007 Jan;153:15.e1-7</i> [PMID 17174630] </p>